Ourui One Wart Complete Care Kit Corn Wart Remover, Ourui One Wart Complete C...

Description

The drug is identified by the SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, imprinted with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, "cauliflower-like" surface and are easily identifiable. Plantar warts are specifically located on the soles of the feet, presenting as tender lesions with an interrupted footprint pattern.

Limitations of Use: This drug is not indicated for any other types of warts or skin lesions. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and soaking the wart in warm water for 5 minutes may enhance the effectiveness of the treatment. After washing, the area must be dried completely.

For the Corn & Wart Remover, a sufficient amount of the product should be applied using a cotton swab to ensure complete coverage of each wart. The application should be allowed to dry. This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

For the Wart Remover Cream, the same initial steps apply: wash the affected area and, if desired, soak in warm water for 5 minutes before drying thoroughly. A small amount of the cream should then be applied to cover each wart, followed by allowing it to dry. This application should be repeated twice daily as needed, also for a maximum of 12 weeks.

Contraindications

Use of CORN & WART REMOVER and WART REMOVER CREAM is contraindicated in the following situations:

• Application on irritated skin or any area that is infected or reddened.

• Use on moles, birthmarks, warts with hair growth, genital warts, or warts located on the face or mucous membranes.

• In patients with diabetes or poor blood circulation, due to the increased risk of complications.

Warnings and Precautions

CORN & WART REMOVER is intended for external use only. It is flammable; therefore, it must be kept away from fire and flame. Users should avoid contact with the eyes. In the event of contact, it is imperative to flush the eyes with water for 15 minutes. This product is non-edible, and it should be stored at room temperature, tightly capped, and away from heat sources.

WART REMOVER CREAM is also for external use only. Care should be taken to avoid contact with the eyes, and if exposure occurs, the eyes should be rinsed with water for 15 minutes. Inhalation of vapors should be avoided. For individuals who are pregnant or breastfeeding, it is recommended to consult a healthcare professional prior to use.

In case of accidental ingestion of either product, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Users should discontinue use of CORN & WART REMOVER and consult a physician if discomfort persists. Similarly, if discomfort continues with WART REMOVER CREAM, users are advised to stop using the product and seek medical advice.

No specific laboratory tests are required for the safe use of these products.

Side Effects

Patients using the Corn & Wart Remover and Wart Remover Cream should be aware of specific warnings and recommendations regarding their use. Both products are intended for external use only and are flammable; therefore, they should be kept away from fire and flame. Additionally, it is crucial to avoid contact with the eyes when using the Wart Remover Cream. In the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water for 15 minutes.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists after application of either product. This precaution is essential to ensure the safety and well-being of the patients.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Ourui One Wart Complete Care Kit Corn Wart Remover, Ourui One Wart Complete Care Kit Wart Remover (salicylic acid 17% wart complete care kit corn wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare providers should carefully evaluate the potential risks and benefits when considering treatment for lactating patients.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the potential risks and benefits.

Overdosage

In the absence of specific information regarding overdosage in the provided sections of the Summary of Product Characteristics (SPL), healthcare professionals are advised to exercise caution and consider general principles of management for suspected overdosage.

Recommended Actions In the event of an overdose, it is essential to assess the patient's clinical status and provide supportive care as necessary. Healthcare professionals should monitor vital signs and be vigilant for any signs of adverse reactions or complications that may arise from the overdosage.

Potential Symptoms While specific symptoms related to overdosage are not detailed, healthcare providers should remain alert to the possibility of unexpected effects, which may vary based on the individual patient's response and the amount ingested.

Management Procedures Management of overdosage should be tailored to the individual case. Supportive measures, including symptomatic treatment and monitoring, are recommended. In cases where the substance is known to have antidotes or specific interventions, these should be employed as appropriate. Consultation with a poison control center or a medical toxicologist may be beneficial for guidance on managing severe cases.

Healthcare professionals are encouraged to report any cases of overdosage to the relevant authorities to contribute to the ongoing assessment of the safety profile of the product.

Nonclinical Toxicology

There is no relevant information available regarding teratogenic effects. For non-teratogenic effects, it is advised that individuals who are pregnant or breastfeeding consult a health professional prior to use. Additionally, no relevant information is provided in the context of nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

Skin discoloration has been reported in postmarketing experience, occurring during or after the use of the product. These events have been documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center at 1-800-222-1222 if the product is swallowed. It is crucial to emphasize the importance of prompt action in such situations.

Patients should be informed to avoid contact with their eyes. In the event that the product does come into contact with the eyes, they should flush the eyes with water for at least 15 minutes and seek medical attention if irritation persists.

Additionally, patients should be instructed that the product is non-edible and should be stored securely. They should cap the product tightly and keep it at room temperature, away from heat sources.

For patients who are pregnant or breastfeeding, it is essential to recommend consulting a healthcare professional before using the product to ensure safety for both the patient and the child.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from excessive heat, specifically temperatures exceeding 37°C (99°F). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

Patients should apply the medication topically, repeating the procedure once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Ourui One Wart Complete Care Kit Corn Wart Remover, Ourui One Wart Complete Care Kit Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)